Apraglutide, A Novel Glucagon-Like Peptide 2 Analog
b'Dr. Kelly Tappenden interviews Dr. Johanna Eliasson, Department of Intestinal Failure and Liver Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, discussing her paper \\u201cApraglutide, a novel glucagon-like peptide 2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: findings from a placebo-controlled, randomized phase 2 trial\\u201d.\\n\\nBusiness Corporate by Alex Menco | alexmenco.net\\nMusic promoted by www.free-stock-music.com\\nCreative Commons Attribution 3.0 Unported License\\ncreativecommons.org/licenses/by/3.0/deed.en_US\\n\\nMay 2022'